Cargando…
THU328 Appropriate Initial Insulin Dosage For Management Of Steroid-induced Hyperglycemia In Hospitalized COVID-19 Patients
Disclosure: N. Ketaroonrut: None. S. Kiertiburanakul: None. C. Sriphrapradang: None. Introduction: Steroid was recommended for the treatment of severe COVID-19 infection. There are limited studies on the management of steroid-associated hyperglycemia in hospitalized COVID-19 patients. We aimed to de...
Autores principales: | Ketaroonrut, Nuttavadee, Kiertiburanakul, Sasisopin, Sriphrapradang, Chutintorn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553385/ http://dx.doi.org/10.1210/jendso/bvad114.762 |
Ejemplares similares
-
THU326 Subcutaneous Insulin Aspart Every 4 Hours In the Treatment Of COVID-19 Patients With Diabetic Ketoacidosis: A Retrospective Study
por: Chiewchalermsri, Dararat, et al.
Publicado: (2023) -
THU260 Development Of Plantar Thermography For Screening Of Diabetic Neuropathy
por: Panamonta, Vipawee, et al.
Publicado: (2023) -
THU289 Hemichorea-Hemiballismus Syndrome Secondary To Steroid Induced Hyperglycemia In A Nondiabetic
por: Krishnaraju, Ellil, et al.
Publicado: (2023) -
THU372 Finasteride Induced Hyperglycemia
por: Bose, Vivek, et al.
Publicado: (2023) -
THU354 Enfortumab Vedotin Induced Refractory Hyperglycemia
por: Hussein, Marwah, et al.
Publicado: (2023)